Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

NCT04105231 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Dual Diagnosis

Interventions

DRUG: Cannabidiol
DRUG: Risperidone

Sponsor

Lone Baandrup

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]